Xinhua Pharmaceutical: Obtained the Drug Registration Certificate for Minodrine Ointment.

Xinhua Pharmaceutical announces that recently it has received the Drug Registration Certificate for the approval of Minoxidil lotion issued by the National Medical Products Administration. Xinhua Pharmaceutical's Minoxidil lotion is used to treat male pattern baldness and alopecia areata. In 2024, the sales revenue of Minoxidil in Chinese public medical institutions is estimated to be around 2.36 billion yuan. The approval of this product is beneficial for enriching the product range and enhancing the company's overall competitiveness.